Z up +1.72% percent Today $Z High is at 106.81 and the Low

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Z up +1.72% percent Today $Z High is at 106.81 and the Low 103.53 with current volume of 533,947.

Recent News posted below.

Zillow Inc. Cl A Z other info.
http://investorshangout.com/Zillow-Inc-Z-55953/

Z Zillow Inc. Cl A Recent Headline News

Zillow Pro for Brokers Adds Achieve Realty
PR Newswire - Mon Nov 10, 7:00AM CST
Zillow, Inc. (NASDAQ: Z), the leading real estate information and home related marketplace, today announced that Pittsburgh-based brokerage Achieve Realty has joined Zillow® Pro for Brokers. Now, Achieve Realty will send its listings directly to Zillow, while enabling its agents to maintain control over their listing data and receive maximum exposure on the Yahoo!-Zillow Real Estate Network, the largest real estate network on the webi, which includes Zillow.com®, Zillow Mobile, HotPads(TM) and Yahoo!® Homes. In addition, Zillow powers real estate search for AOL® Real Estate, MSN® and HGTV®'s FrontDoor®.
Z: 106.06 (+2.86)

Zillow to Participate in November Investor Conferences
GlobeNewswire - Fri Nov 07, 5:41PM CST
Zillow, Inc. (Nasdaq:Z), the leading real estate information marketplace, today announced that Zillow(R) executives will participate in the following November investor conferences:
Z: 106.06 (+2.86)

Zillow Tumbles As Display Ads Decline
at Investor's Business Daily - Thu Nov 06, 11:23AM CST
Shares of No. 1 online real estate website Zillow crumbled Thursday after the company's revenue forecast fell short of analyst expectations. Late Wednesday, the Seattle-based Zillow (Z) guided Q4 revenue of $89 million to $90 million, up 53% at the...
TRLA: 45.08 (+0.82), Z: 106.06 (+2.86)

ZILLOW (Z) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 9:45AM CST
The following ZILLOW (Z) conference call took place on November 5, 2014, 05:00 PM ET. This is a transcript of that earnings call:
Z: 106.06 (+2.86)

Marriott, Coke and Others Utilizing Oculus Rift as Virtual Reality Could Transform Industries
ACCESSWIRE - Thu Nov 06, 8:40AM CST
Whitefish, MT / November 6, 2014 / Most people have seen a "virtual tour" of something, such as videos of houses for sale on Zillow (NYSE:Z) or the new virtual tour of the One World Trade Center observatory, but that technology still doesn't really give a person a feeling of being there because it still lacks a full perspective. Imagine when the user is in full control; able to back up, look down and around and the video responds accordingly. What about any audio, which still lacks direction in existing so-called virtual tours? That's what virtual reality (VR) is going to bring to the table and it's going to transform much more than just gaming with its endless possibilities and applications.
KO: 42.38 (+0.06), CCL: 40.20 (-0.20), FB: 74.92 (-0.68), SNE: 20.56 (+0.94), FCAU: 11.07 (+0.13), TM: 118.11 (-0.56), MAR: 76.10 (+0.60), OWW: 7.54 (-0.14), EXPE: 86.04 (+0.93), Z: 106.06 (+2.86)

Zillow Real Estate App Adds New Features for Agents
PR Newswire - Thu Nov 06, 7:00AM CST
Zillow, Inc. (NASDAQ: Z), the leading real estate information and home related marketplace, today announced it has introduced several new features to the existing Zillow® Real Estate Application exclusively for Zillow Premier Agents and agents who have a free Zillow profile. The new features are designed to help agents respond faster and more effectively to new contacts they receive from Zillow, and allows for agents to easily manage their Zillow contacts, profile and listings on their mobile device.
Z: 106.06 (+2.86)

Zillow Earnings: Bringing Home Another Great Quarter
Steve Symington, The Motley Fool - Motley Fool - Wed Nov 05, 6:13PM CST
Zillow just reported solid third-quarter 2014 results, and the market isn't pleased. Shares of Zillow fell over 9% after it said quarterly revenue climbed 66% year over year to $88.6 million, or just above Zillow's previous guidance for revenue...
BAC: 17.32 (-0.04), TRLA: 45.08 (+0.82), AAPL: 109.00 (-0.01), Z: 106.06 (+2.86)

ZILLOW
at Investor's Business Daily - Wed Nov 05, 5:41PM CST
ZILLOW (Z) Q3 revenue rose 66.3% to $88.65 mil, just above views for $88 mil. The real estate site, swung to EPS ex items of 13 cents vs. a 5-cent loss last year. Wall St. expected EPS of 8 cents. But shares dived 9.8% to 93.58.
Z: 106.06 (+2.86)

Zillow Plunges as Sales Forecasts Fall Short of Wall Street Expectations
at The Street - Wed Nov 05, 4:53PM CST
Zillow shares continued to fall in after-hours trades even though the company posted its sixteenth quarter of more than 65% year-over-year revenue growth.
TRLA: 45.08 (+0.82), Z: 106.06 (+2.86)

Zillow reports 3Q loss
Automated Insights - Wed Nov 05, 4:09PM CST
SEATTLE (AP) _ Zillow Inc. (Z) on Wednesday reported a loss of $16 million in its third quarter.
Z: 106.06 (+2.86)

Zillow, Inc. Reports Record Third Quarter 2014 Results
GlobeNewswire - Wed Nov 05, 3:36PM CST
-- Record quarterly Revenue of $88.6 million, up 66% over third quarter 2013.
Z: 106.06 (+2.86)

Technology M&A Activity Maintains Brisk Pace In Q3
at Investor's Business Daily - Wed Nov 05, 1:49PM CST
The combined value of mergers and acquisitions that closed in the technology sector during the third quarter rose 9% from Q2 to $30.1 billion. There were eight billion-dollar deals in the quarter, compared with an average of six per quarter over the...
CNQR: 128.28 (+0.07), SAP: 67.27 (+0.42), TRLA: 45.08 (+0.82), AAPL: 109.00 (-0.01), PCLN: 1,106.51 (+11.90), ORCL: 40.44 (+0.50), Z: 106.06 (+2.86)

Will Zillow (Z) Surprise Earnings Estimates This Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 3:32PM CST
Online real estate information provider Zillow (Z) is set to report the third-quarter 2014 results on Nov 5, 2014.
LMOS: 15.70 (-0.32), MANU: 15.78 (-0.08), NWSA: 15.19 (+0.04), Z: 106.06 (+2.86)

30-Year Fixed Mortgage Rates Spike on News of Stimulus Program Ending, Flatten Out by Week's End; Current Rate is 3.90%, According to Zillow Mortgage Rate Ticker
GlobeNewswire - Tue Nov 04, 1:45PM CST
The 30-year fixed mortgage rate on Zillow(R) Mortgages is currently 3.90 percent, up five basis points from this time last week. The 30-year fixed mortgage rate hovered around 3.92 percent for most of the week, spiking to 4.15 percent Thursday before settling around the current rate.
Z: 106.06 (+2.86)

3 Thing to Watch When Zillow Inc. Reports Earnings
Steve Symington, The Motley Fool - Motley Fool - Tue Nov 04, 12:00PM CST
Zillow   announces third quarter 2014 results this Wednesday November 5, 2014 after the closing bell, so it's time for investors to start thinking about what to expect from the online real estate maven.   Zillow has already told investors revenue...
TRLA: 45.08 (+0.82), Z: 106.06 (+2.86)

Zillow to Launch Zillow Tech Connect: Reviews
PR Newswire - Tue Nov 04, 7:00AM CST
Zillow, Inc. (NASDAQ: Z), the leading real estate information and home-related marketplace, today announced the launch of Zillow® Tech Connect: Reviews. For the first time, brokers, agents and MLSs will be able to display individual agents' Zillow reviews on their website through Zillow Tech Connect.
Z: 106.06 (+2.86)

Disrupting Regulation: Uber, AirBnB, and Tesla Challenge the Status Quo
Rich Duprey, The Motley Fool - Motley Fool - Mon Nov 03, 9:00AM CST
Uber and AirBnb may be among the most visible manifestations of the so-called "shared economy" revolution under way in delivering consumer services, but it's also popping up in areas not typically associated with peer-to-peer platforms and ultimately...
TSLA: 241.58 (+1.38), LMT: 186.87 (+0.72), V: 249.74 (-2.69), CAR: 57.56 (-0.11), BA: 124.61 (+0.16), MA: 84.72 (-0.08), CVC: 18.54 (-0.38), Z: 106.06 (+2.86), CBS: 51.96 (+0.65)

Millions of Potential New Households Waiting Out the Recovery
PR Newswire - Mon Nov 03, 7:00AM CST
Stagnant incomes and rising rents left the U.S. with an unprecedented number of doubled-up households as people moved in together to make ends meet. All those roommates have changed the American housing landscape, with 5.4 million households that would exist under normal conditions instead lost in guestrooms and basements, sharing space with friends, family and roommates, waiting for better economic times, according to an analysis by Zillow.
Z: 106.06 (+2.86)

Trulia Inc. Q3 Earnings: Ready For The Buyout
Eric Volkman, The Motley Fool - Motley Fool - Fri Oct 31, 9:48AM CDT
In what may well be its final quarterly earnings report as a stand-alone company, online real estate portal Trulia handed down its Q3 results. They showed a lot of red ink, although they were more or less in line with estimates. On a more...
TRLA: 45.08 (+0.82), Z: 106.06 (+2.86)

Trulia Q3 Miss Driven By Refi Weakness, Stock Falls
at Investor's Business Daily - Thu Oct 30, 1:56PM CDT
Online real estate listings company Trulia (TRLA) late Wednesday posted Q3 revenue below its guidance for the first time, and its stock tumbled Thursday. Trulia stock was down 2.5% in afternoon trading in the stock market today, near 43.50. Earlier,...
TRLA: 45.08 (+0.82), Z: 106.06 (+2.86)

Zillow Inc. (Z) Stock Research Links

Z Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 308

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 412

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 106

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 130

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 288

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 127

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Expanding Horizons: Future of IVD Contract Manufacturing

Updated Category News Views 117

The Growing Landscape of IVD Contract Manufacturing The in vitro diagnostics (IVD) contract manufacturing market is on the brink of significant expansion, anticipated to reach a staggering USD 39.74 billion by 2031. This growth represents a compounded annual growth rate (CAGR) of 11.60% from 2024 to 2031, driven chiefly by the needs of the healthcare industry to keep pace...

Continue Reading
Citi Upgrades AerCap Holdings Price Target to $117 Amid Strong Performance

Updated Category News Views 79

Citi Upgrades AerCap Holdings Price Target Citi has recently updated its outlook on AerCap Holdings (NYSE:AER), raising the price target to $117 from $113. This move reflects Citi's confident stance on the aircraft leasing company's financial health within the aviation sector. By reaffirming their buy rating, the firm signals strong expectations for AerCap's growth...

Continue Reading
LG Energy Solution Reports Strong Q2 2025 Financial Performance

Updated Category News Views 750

LG Energy Solution Achieves Remarkable Financial Milestones In a significant announcement, LG Energy Solution has revealed its performance for the second quarter of 2025, detailing impressive results that demonstrate the company's resilience and strategic focus on growth. With consolidated revenue of KRW 5.6 trillion and an operating profit of KRW 492.2 billion, the...

Continue Reading
Genpact Shines as a Leader in Sustainability Recognition

Updated Category News Views 264

Genpact's Sustainable Initiatives Gain Global Recognition Recently, Genpact (NYSE: G), an advanced technology services provider, received significant acclaim for its commitment to sustainability. Being featured in TIME's prestigious list of the World's Best Companies in Sustainable Growth for 2025 showcases their dedication to ethical business practices and innovation. A...

Continue Reading
Medical Express Ambulance Faces Data Breach Investigation

Updated Category News Views 344

Understanding the Data Breach Investigation Edelson Lechtzin LLP, a prominent class action law firm, is currently looking into data privacy concerns affecting customers of Medical Express Ambulance, Inc. (MedEx). MedEx has reported potential unauthorized access to its network, raising significant alarm regarding the safety of customer data. Medical Express Ambulance, Inc....

Continue Reading